Posted inCardiology, Metabolism, New Drugs, Regulatory Camzyos: First Specific Drug to Treat Hypertrophic Cardiomyopathy April 29, 2022April 5, 2024 Mavacamten by Bristol-Myers Squibb is a new breath for all patients with obstructive hypertrophic cardiomyopathy.
